Introduction
============

Since the 1990s, the incidence of thyroid cancer has increased, faster than any other cancer type in the US. Over the past 3 decades, the incidence of thyroid cancer has increased 240%.[@b1-cmar-9-627] Currently, there are 56,780 new thyroid cancer patients in the US.[@b2-cmar-9-627] Although the mortality of thyroid cancer is not very high compared with other cancers, there are some subtypes of thyroid cancer that are more aggressive and needed more positive treatment.

Surgery and radioiodine therapy are the two main recommended approaches. Thyroidectomy is frequently recommended to patients with thyroid nodules, especially for those in whom thyroid cancer is suspected of carrying thyroid cancer.[@b3-cmar-9-627],[@b4-cmar-9-627] The completeness of surgical resection helps to improve survival and lower recurrence; thus, most surgeons proposed total thyroidectomy over thyroid lobectomy.[@b5-cmar-9-627] However, compared with thyroid lobectomy, there is a higher incidence risk of complications after total thyroidectomy. Complications of these surgical procedures are numerous, and some of them are severe and persistent over time,[@b6-cmar-9-627],[@b7-cmar-9-627] including hypoparathyroidism, hypocalcemia, vocal paralysis, and hemorrhage. Transient hypocalcemia is one of the most common postoperative complications following thyroid surgery in clinical practice.[@b8-cmar-9-627],[@b9-cmar-9-627] It has been reported that the rate of postoperative transient hypocalcemia ranges from 6% to 30%,[@b10-cmar-9-627]--[@b12-cmar-9-627] although there is ≤2% incidence of persistent dysfunction. The nadir of hypocalcemia often appears within 48 hours after thyroidectomy.[@b13-cmar-9-627],[@b14-cmar-9-627] Symptoms are severe and, requiring calcium replacement therapy.

In many cases, serum calcium levels recover spontaneously within a few months. However, in a few patients, hypoparathyroidism persists after 1 year and may be considered permanent.[@b15-cmar-9-627] The occurrence of permanent hypocalcemia is mainly attributed to postoperative hypoparathyroidism when parathyroid glands are devascularized, injured, or dissected during the surgery.[@b15-cmar-9-627],[@b16-cmar-9-627] The hypocalcemia after surgery is related to multiple factors, including surgical technique, the definition of hypocalcemia, criteria of report series, and use of prophylactic calcium supplementation in the perioperative period.[@b16-cmar-9-627],[@b17-cmar-9-627]

Postoperative hypocalcemia can not only cause clinical symptoms but can also become a major contributing factor of prolonged hospitalization time for close observation and frequent laboratory evaluations.[@b11-cmar-9-627],[@b18-cmar-9-627] The aim of this study was to investigate the frequency and risk factors for post-thyroidectomy hypocalcemia and hypoparathyroidism following thyroidectomy.

Patients and methods
====================

Enrollment of patients
----------------------

We performed a retrospective analysis of patients who underwent total thyroidectomy or lobectomy surgery at The First Affiliated Hospital of Wenzhou Medical University from 2012 to 2014. During surgery, all or partial thyroid tissue was removed, including the posterior capsule and pyramidal lobe, varying upon patient condition. All parathyroid glands were identified. The viable parathyroids were identified and if possible preserved on an intact vascular pedicle, and those that appeared nonviable or could not be preserved were removed, placed in cold saline, and minced into 11 mm fragments; parathyroid slivers were autotransplanted to a muscle bed in the sternocleidomastoid or the nondominant forearm.

This study obtained ethical approval from the Institutional Review Board of First Affiliated Hospital of Wenzhou Medical University (approval no. 2012-57). In addition, the medical directors' offices of the hospital granted permission to use the patients' data for this study. All data had no personal identifiers and were kept confidential and therefore did not require informed consent.

A total number of 278 consecutive patients were finally enrolled with criteria as follows. The serum calcium and parathyroid hormone (PTH) level of patients were tested preoperatively and 48 hours after the operation, respectively. In our hospital, we routinely tested the preoperative PTH in order to exclude postoperative hypocalcemia and hypoparathyroidism. All patients were routinely supplemented with calcium through intravenous injection, and dose adjustment of calcium and appropriate amounts of vitamin D was managed based on clinical symptoms. In all, patients with symptoms of hypocalcemia or hypoparathyroidism occured for a period of 1 month after the surgery is usually temporary. If the symptoms were not alleviated after 6 months postoperatively, hypocalcemia or hypoparathyroidism symptoms could be seen as permanent. Hypocalcemia and hypoparathyroidism were diagnosed according to the American Thyroid Surgery Society 2009 guideline.[@b19-cmar-9-627]

There was a significant association between preoperative PTH and postoperative hypocalcemia and hypoparathyroidism.

Patients were finally enrolled with exclusion criteria as follows: Patients had hypocalcemia or abnormal parathyroid function before the surgery.Patients had a history of thyroid or neck surgery. All patients were operated on by Xiao-hua Zhang, Cheng-ze Chen, and Ying-hao Wang.

Collection of clinicopathological parameters and study protocol
---------------------------------------------------------------

Demographic, pathologic, and laboratory data of all enrolled patients were collected from electronic medical records. Clinicopathological data collected encompassed age, gender, and preoperative and postoperative corrected serum calcium and PTH levels. In addition, information on the type of operation, operative time, and intraoperative management of the parathyroid gland was obtained from the surgical records. Patients were defined as having hypocalcemia if the serum calcium value was \<2.0 mmol/L 48 hours after an operation or related symptoms were present, and oral treatment with calcium and calcitriol was started if the serum calcium level dropped below this value. This selective therapeutic strategy allows for patients to be discharged home early on the next day and minimizes overtreatment of the normocalcemic patients.

Among patients with hypocalcemia, we further defined them as with hypoparathyroidism, once the postoperative serum PTH value was \<15 pg/mL.

Application of carbon nanoparticle (CN) suspension injection
------------------------------------------------------------

CN suspension injection was applied in the form of a standard CN suspension injection (1 mL: 50 mg). The suspension does not enter the blood circulation and has no toxic side effects on the human body.[@b20-cmar-9-627] The suspension comprises nanosized carbon particles with an average diameter of 150 nm. The cell gap between capillary endothelial cells is 20--50 nm, and the capillary lymphatic endothelial cell gap is 120--500 nm with a hypoplasia of the basement membrane. Therefore, CN is unable to enter the blood vessels when it is injected into the thyroid tissue, and it will rapidly enter lymphatic vessels or the lymphatic capillaries through macrophage phagocytosis and be retained in the lymph nodes. The thyroid and lymph in their drainage areas are stained black in surgery.[@b20-cmar-9-627] However, the parathyroid glands do not stain black, and hence, the black-stained thyroid and lymph nodes can be identified and are distinguished clearly. After cutting along the white cervical line, the thyroid gland can be identified carefully eliminating the false fibrous capsule from the thyroid gland and revealing the gland near the isthmus. Unnecessary freed gland can cause damage to the surrounding lymphatic network and influence the effects of CNs after injection. The integrity of the fibrous capsule of thyroid glands must be maintained. Damage of the fibrous capsule of thyroid glands can cause a leakage of CN suspension, resulting in the entire operative field stained black, which will render it impossible to distinguish the parathyroid gland and increase surgical risk. One injection of 0.1 mL CN suspension injection was administered with a fine needle in the lower one-third of the ventral surface to each of the bilateral glands, and the injection depth was roughly within the upper third of the glands. Too deep or shallow an injection can also cause the extravasation of CN suspension, which can result in a black-stained surgical field and increase the risk of surgery. All of the abovementioned factors are essential to take into consideration when performing the injection. Thus, the injection requires extra care. The needle must avoid the tumor, and the surgeon must proceed to inject slowly if no blood is found upon pump back during injection of the suspension. After injecting the needle, pressure must be applied for 1--2 minutes with a gauze and this allows the full staining of the suspension injection in the thyroid gland, parathyroid glands and lymph nodes.

Statistical analysis
--------------------

Measurement data on normal distribution are expressed as the mean ± standard deviation (SD) and were compared with the two-sample *t*-test. Categorical data are expressed as a percentage and were compared with chi-square test or Fisher's exact test, as appropriate. Logistic regression analysis was also performed to estimate the odds ratios (ORs) of certain parameters. A *P* value of \<0.05 was considered as statistically significant. Statistical analysis was performed with SPSS software version 22.0 (IBM Corp., Armonk, NY, USA).

Results
=======

Baseline characteristics
------------------------

A total of 278 patients who underwent thyroid operations were included in the study, including 218 women and 60 men. [Table 1](#t1-cmar-9-627){ref-type="table"} lists the baseline clinicopathological characteristics of enrolled patients. Postoperative hypocalcemia occurred in 76 (27.3%) patients, and hypoparathyroidism occurred in 42 (15.1%) patients. [Table 2](#t2-cmar-9-627){ref-type="table"} lists the usage status of CN suspension injection in different operations.

Risk factors for postoperative hypocalcemia
-------------------------------------------

To discover potential risk factors for postoperative hypocalcemia, the patients were divided into two groups. [Table 3](#t3-cmar-9-627){ref-type="table"} lists the differences in clinicopathological characteristics between the two groups. Among these, eight factors were significantly related to the presence of postoperative hypocalcemia, namely, age (*P*=0.049), gender (*P*=0.015), lateral lymph node dissection (*P*=0.017), operation type (*P*\<0.001), preoperative PTH level (*P*=0.035), operation time (*P*=0.001), parathyroid autotransplantation (*P*=0.002), and applying CNs (*P*=0.007). However, pathology, central lymph node dissection, parathyroid inadvertent dissection, number of identified parathyroid glands, and preoperative serum calcium levels were not significantly correlated with the presence of postoperative hypocalcemia (*P*\>0.05). Multivariate analyses showed that age (*P*=0.038), lateral lymph node dissection (*P*=0.050), operation type (*P*\<0.001), and applying CNs (*P*=0.036) were independent predictors for postoperative hypocalcemia ([Table 4](#t4-cmar-9-627){ref-type="table"}).

Risk factors for postoperative hypoparathyroidism
-------------------------------------------------

Next, we detected potential risk factors for postoperative hypoparathyroidism. Our results revealed that gender (*P*=0.014), lateral lymph node dissection (*P*=0.038), operation type (*P*\<0.001), operative time (*P*\<0.001), parathyroid autotransplantation (*P*\<0.001), and applying CNs (*P*=0.001) had a significant correlation with postoperative hypoparathyroidism ([Table 3](#t3-cmar-9-627){ref-type="table"}). Multivariate analysis showed that operation type (*P*\<0.001), gender (*P*=0.026), and preoperative PTH level (*P*=0.006) were independent predictors for postoperative hypoparathyroidism ([Table 5](#t5-cmar-9-627){ref-type="table"}).

Discussion
==========

Hypocalcemia and hypoparathyroidism are a frequent complication of thyroidectomy with the growing incidence of thyroid disease.[@b21-cmar-9-627],[@b22-cmar-9-627] The increased incidence of hypocalcemia in post-thyroidectomy patients may be attributed to hemodilution. Earlier studies also provide various other factors such as age, basic pathology, and duration of surgery as reasons for increased incidence of hypocalcemia.[@b23-cmar-9-627] When all glands are compromised by injury of the vascular pedicle, resection or unintended surgical manipulation and sudden significant fall in levels of PTH occur, leading to more intense and faster hypocalcemia, hence causing the symptoms. With partial preservation of the function of the parathyroid glands, the PTH decrease is less significant, remaining so until there is retrieval or repair of the remaining glands of the ischemic parathyroid cells. In such cases, the calcium concentration falls more slowly and with less intensity, lesser possible to cause clinical symptoms. Searching for parathyroid glands may, theoretically, increase the risk of them being injured, being a contributing factor to hypocalcemia.[@b24-cmar-9-627],[@b25-cmar-9-627]

Hypocalcemia occurs secondary to hypoparathyroidism due to trauma, devascularization, or removal of the parathyroid glands that leads to prolonged hospitalization, increased medical cost, and patient discomfort.[@b26-cmar-9-627],[@b27-cmar-9-627] Therefore, it is necessary to find risk factors for hypocalcemia and hypoparathyroidism following thyroidectomy and to help guide clinical practice.

In this study, we performed a retrospective analysis of 278 patients and used statistical tools to analyze clinical data. Collectively, our results demonstrate that gender, lateral lymph node dissection, operation type, operation time, and use of CNs were related to the occurrence of hypocalcemia and hypoparathyroidism.

In 2012, "Management Guidelines of Thyroid Nodules and Differentiated Thyroid Cancer" was made by Chinese Society of Endocrinology, Chinese Society of Surgery, China, Anti-Cancer Association of Head and Neck Specialized Committee, and Chinese Society of Nuclear Medicine depending on management guidelines made by American Thyroid Association (ATA), European Society for Medical Oncology (ESMO), and American Association of Clinical Endocrinologists (AACE). In this guideline, it recommended prophylactic central lymph nodes dissection with the preservation of recurrent laryngeal nerve and parathyroid glands. According to this guideline, whether to perform dissection of central lymph nodes depends on pathologic characteristics and surgeon skills, rather than surgery type. Surgery type is more dependent on tumor size, single or multiple nodules, invasion of adjacent tissues, lymphatic metastasis, metastasis, radiation in childhood, family history of thyroid cancer or subtype, and so on. In addition, whether to perform lateral lymph node dissection depends on patients with lateral lymph node metastasis or part of patients with central lymph node metastasis.

Patients with evidence of nodal disease require therapeutic neck dissection. When disease is restricted to the central compartment, clearance of levels VI and VII is suggested. Therapeutic central-compartment neck dissection for patients with clinically involved central nodes should undergo total thyroidectomy to provide clearance of disease from the central neck. The recurrent laryngeal nerves should be carefully dissected and preserved, and the parathyroid glands should be identified and preserved along with their blood supply. When the parathyroid glands are devascularized, they may require autotransplantation in the sternocleidomastoid muscle. In patients with proven lateral neck disease, therapeutic neck dissection is indicated and can be done in a rather selective manner. Rates of metastasis in levels I, IIb, and Va are low, and are in the absence of proven disease, these levels can be spared to avoid morbidity, especially to the marginal mandibular and spinal accessory nerves. The lateral neck dissection should normally entail levels IIa through Vb and can be done simply by continuing the thyroidectomy, central neck dissection incision laterally within the same skin crease. In thyroid cancer, special attention should be paid to nodal tissue posterior to the great vessels in level IV, as this is a common site for recurrent nodal disease. Besides, lymph mode metastases are often found very low in the base of the neck, and dissecting this area may increase the risk for substantial vascular and lymphatic injury.[@b28-cmar-9-627]

We found that female patients were vulnerable to postoperative hypoparathyroidism. Serum calcium is regulated by 1,25-dihydroxyvitamin D or calcitriol through bone resorption, PTH through calcium reabsorption of renal tubules, and calcitriol through calcium intestinal absorption.[@b29-cmar-9-627] This phenomenon may be attributed to the dropping hormone levels in menopausal women.[@b30-cmar-9-627],[@b31-cmar-9-627] Previous studies also showed that intrathyroidal parathyroid glands were more frequent in women owing to the high occurrence rates of parathyroid injury and hypocalcemia.[@b32-cmar-9-627]--[@b34-cmar-9-627]

In fact, vitamin D level may be a really important preoperative risk factor in predicting the postoperative hypocalcemia. Griffin et al[@b35-cmar-9-627] found that vitamin D does not play a significant role in the occurrence of postoperative hypocalcemia. This result is in accordance with other studies.[@b36-cmar-9-627],[@b37-cmar-9-627] Recently, Danan and Shonka[@b26-cmar-9-627] demonstrated that vitamin D level is a significant predictor of postoperative hypocalcemia in patients in whom ≥3 parathyroid glands were identified. However, in our retrospective study, we did not have the data for preoperative vitamin D levels. We believe that this complicated risk factor needs further investigation.

In our analysis, we found that parathyroid autotransplantation is a risk factor for postoperative hypoparathyroidism. Many analyses have demonstrated that parathyroid autotransplantation plays an important role in avoiding permanent hypoparathyroidism and should be a routine surgery.[@b38-cmar-9-627]--[@b40-cmar-9-627] After autotransplantation, grafted parathyroid required time to regain its function.[@b41-cmar-9-627] We also demonstrated that parathyroid autotransplantation increases the risk of postoperative hypoparathyroidism.

It is well known that different types of thyroid disease need appropriate excision extension, which affects operation time. The extent of thyroidectomy, which depends on the pathology and operation method, is significantly related to the frequency of postoperative hypoparathyroidism.[@b42-cmar-9-627] Certainly, isolation of the recurrent laryngeal nerve during surgery can attribute to venous congestion and edema. Besides, ligation of thyroid blood vessels also disrupts the stasis of blood supply. Edema and blood supply stasis have a negative influence on parathyroid function and may induce a transient hypoparathyroidism lasting for ≥1 week after surgery.[@b43-cmar-9-627] In our study, the surgical method played a dominant role in causing postoperative hypoparathyroidism. The near-total thyroidectomy and total thyroidectomy were independent risk factors attributing to hypothyroidism (*P*=0.001, OR=10.502, 95% CI: 2.726--40.466; *P*\<0.001, OR=44.647, 95% CI: 13.541--147.207). Similarly, Nawrot et al[@b44-cmar-9-627] have demonstrated that hypoparathyroidism was more frequently seen after total thyroidectomy (20.2%) than near-total thyroidectomy (6.7%) or subtotal thyroidectomy (4.1%). González-Botas and Piedrahita[@b45-cmar-9-627] and Merchavy et al[@b46-cmar-9-627] have reported that postoperative hypocalcemia was less common in patients with completion thyroidectomy than in patients who underwent total thyroidectomy.

Shen et al[@b47-cmar-9-627] have demonstrated that the incidence of hypoparathyroidism was statistically significant between patients who underwent thyroidectomy with or without neck lymph node dissection. Similarly, we found that patients with lateral lymph node dissected showed a higher incidence of hypocalcemia and hypoparathyroidism than those without receiving lateral lymph node dissection (*P*=0.017; *P*=0.038). Actually, parathyroid blood vessels are thin, fragile, and terminal; parathyroid blood supply is easily affected or disrupted, which may result in the high occurrence of hypocalcemia after lateral lymph node dissection.[@b48-cmar-9-627]

CN suspension injection is applied for helping identify lymph nodes in lymph node dissection, including breast cancer and gastrointestinal cancer.[@b49-cmar-9-627]--[@b51-cmar-9-627] Because the components for CN suspension injections are nanocarbon granules, these have diameters of 150 nm and they can enter lymphatic capillaries (diameters of 500 nm) rather than blood vessel capillaries (diameters of 30--50 nm) and immediately enter into drainage lymph nodes.[@b52-cmar-9-627] Furthermore, recent studies have shown that CN suspension injection can aid in identifying parathyroid glands, which may provide a new strategy for identification and protection during parathyroid surgery.[@b52-cmar-9-627],[@b53-cmar-9-627]

Results
=======

Our results have shown, with the aid of CN suspension, that incidence of hypocalcemia and hypoparathyroidism is lower, which implies that CNs could help to distinguish the parathyroid glands from thyroid tissue. This result is in accordance with previous research.[@b54-cmar-9-627],[@b55-cmar-9-627]

Conclusion
==========

Postoperative hypocalcemia and hypoparathyroidism incidence were significantly related to the extent of thyroidectomy, gender, lateral lymph node dissection, operative time, and use of CNs. These findings were crucial for guiding surgeons to prevent the occurrence of hypocalcemia and hypoparathyroidism.
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###### 

Baseline characteristics of enrolled patients

  Variables                                              n (%)
  ------------------------------------------------------ -------------
  Age (years), mean ± SD                                 48±11
  Gender                                                 
   Female                                                218 (78.42)
   Male                                                  60 (21.58)
  Pathology                                              
   Benign                                                81 (29.14)
   Malignant                                             197 (70.86)
  Central lymph node dissection                          
   No                                                    100 (35.97)
   Yes                                                   178 (64.03)
  Lateral lymph node dissection                          
   No                                                    240 (86.33)
   Yes                                                   38 (13.67)
  Parathyroid inadvertent dissection                     
   No                                                    247 (88.85)
   Yes                                                   31 (11.15)
  Operation                                              
   Lobectomy                                             137 (49.28)
   Lobectomy plus isthmusectomy                          62 (22.30)
   Near-total thyroidectomy                              30 (10.79)
   Total thyroidectomy                                   49 (17.63)
  Postoperative hypocalcemia                             
   No                                                    202 (72.66)
   Yes                                                   76 (27.34)
  Postoperative hypoparathyroidism                       
   No                                                    236 (84.89)
   Yes                                                   42 (15.11)
  No. of patients with parathyroid autotransplantation   52 (18.71)
   One parathyroid gland                                 48 (17.27)
   Two parathyroid glands                                4 (1.44)
  Inadvertent removal of the parathyroid glands          31 (11.15)
   One parathyroid gland in specimen                     30 (10.79)
   Two parathyroid glands in specimen                    1 (0.36)

**Abbreviation:** SD, standard deviation.

###### 

Usage status of CN suspension injection in different operations

  Operation                      CN suspension injection, n (%)   
  ------------------------------ -------------------------------- ------------
  Lobectomy                      45 (47.37)                       92 (50.27)
  Lobectomy plus isthmusectomy   13 (13.68)                       49 (26.78)
  Near-total thyroidectomy       6 (6.32)                         24 (13.11)
  Total thyroidectomy            31 (32.63)                       18 (9.84)

**Abbreviation:** CN, carbon nanoparticle.

###### 

Univariate analysis for risk factors for postoperative hypocalcemia and hypoparathyroidism

                                                  Postoperative hypocalcemia   *χ*^2^/*t*    *P*-value   Postoperative hypoparathyroidism   *χ*^2^/*t*    *P*-value              
  ----------------------------------------------- ---------------------------- ------------- ----------- ---------------------------------- ------------- ------------- -------- -------
  Number                                          202                          76                                                           236           42                     
  Age (years), mean ± SD                          47±11                        50±12         1.976       0.049                              47±11         48±12         0.535    0.592
  Gender                                                                                     5.864       0.015                                                          6.095    0.014
   Female                                         151                          67                                                           179           39                     
   Male                                           51                           9                                                            57            3                      
  Pathology                                                                                  1.506       0.239                                                          1.424    0.272
   Benign                                         63                           18                                                           164           33                     
   Malignant                                      139                          58                                                           72            9                      
  Central lymph node dissection                                                              2.240       0.161                                                          2.055    0.167
   No                                             78                           22                                                           89            11                     
   Yes                                            124                          54                                                           147           31                     
  Lateral lymph node dissection                                                              6.708       0.017                                                          4.311    0.038
   No                                             181                          59                                                           208           32                     
   Yes                                            21                           17                                                           28            10                     
  Parathyroid inadvertent dissection                                                         1.165       0.290                                                          2.246    0.134
   No                                             182                          65                                                           213           34                     
   Yes                                            20                           11                                                           23            8                      
  Operation                                                                                  24.664      0.000                                                          69.078   0.000
   Lobectomy                                      112                          25                                                           133           4                      
   Lobectomy plus isthmusectomy                   49                           13                                                           58            4                      
   Near-total thyroidectomy                       17                           13                                                           23            7                      
   Total thyroidectomy                            24                           25                                                           22            27                     
  Preoperative serum calcium level, mean ± SD     2.31±0.11                    2.29±0.10     1.384       0.167                              2.30±0.11     2.32±0.10     1.100    0.272
  Preoperative PTH level, mean ± SD               34.34±10.21                  38.02±18.42   2.109       0.035                              35.49±10.96   34.53±21.48   0.438    0.661
  Operative time (minutes), mean ± SD             66±27                        79±39         3.144       0.001                              66±25         93±48         5.452    0.000
  CNs                                                                                        8.096       0.007                                                          11.604   0.001
   Injected                                       59                           36                                                           71            24                     
   Non-injected                                   143                          40                                                           169           18                     
  Parathyroid autotransplantation                                                            9.198       0.002                                                          42.3     0.000
   No                                             173                          53                                                           207           19                     
   Yes                                            29                           23                                                           29            23                     
  Inadvertent removal of the parathyroid glands                                              1.165       0.28                                                           N        0.106
   No                                             182                          65                                                           213           34                     
   Yes                                            20                           11                                                           23            8                      

**Note:** N indicates this group is not suitable for chi-square test but fisher exact test.

**Abbreviations:** SD, standard deviation; PTH, parathyroid hormone; CN, carbon nanoparticle.

###### 

Multivariable logistic regression for risk factors for postoperative hypocalcemia

  Variables                                        Coefficient   Standard error   Wald value   *P*-value   OR      95% CI   
  ------------------------------------------------ ------------- ---------------- ------------ ----------- ------- -------- -------
  Age (years)                                      0.028         0.013            4.298        0.038       1.028   1.002    1.055
  Lateral lymph node dissection                                                                                             
   Yes versus no                                   0.759         0.388            3.832        0.050       2.137   0.999    4.570
  Operation                                                                                    0.000                        
   Lobectomy plus isthmusectomy versus lobectomy   0.161         0.392            0.168        0.682       1.174   0.545    2.531
   Near-total thyroidectomy versus lobectomy       1.388         0.441            9.904        0.002       4.005   1.688    9.503
   Total thyroidectomy versus lobectomy            1.310         0.378            12.035       0.001       3.708   1.768    7.774
  CNs                                                                                                                       
   Injected versus non-injected                    0.644         0.308            4.375        0.036       1.904   1.041    3.480

**Abbreviations:** OR, odds ratio; CN, carbon nanoparticle.

###### 

Multivariable logistic regression for risk factors for postoperative hypoparathyroidism

  Variables                                        Coefficient   Standard error   Wald value   *P*-value   OR       95% CI   
  ------------------------------------------------ ------------- ---------------- ------------ ----------- -------- -------- ---------
  Gender                                                                                                                     
   Male versus female                              --1.583       0.709            4.988        0.026       0.205    0.051    0.824
  Preoperative PTH level                           --0.066       0.024            7.528        0.006       0.936    0.894    0.981
  Operation                                                                                    0.000                         
   Lobectomy plus isthmusectomy versus lobectomy   0.619         0.735            0.709        0.400       1.857    0.440    7.844
   Near-total thyroidectomy versus lobectomy       2.352         0.688            11.676       0.001       10.502   2.726    40.466
   Total thyroidectomy versus lobectomy            3.799         0.609            38.946       0.000       44.647   13.541   147.207

**Abbreviations:** OR, odds ratio; PTH, parathyroid hormone.
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